These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

535 related articles for article (PubMed ID: 28961210)

  • 1. A New Series of Cytotoxic Pyrazoline Derivatives as Potential Anticancer Agents that Induce Cell Cycle Arrest and Apoptosis.
    Wang H; Zheng J; Xu W; Chen C; Wei D; Ni W; Pan Y
    Molecules; 2017 Sep; 22(10):. PubMed ID: 28961210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and Evaluation of New Pyrazoline Derivatives as Potential Anticancer Agents in HepG-2 Cell Line.
    Xu W; Pan Y; Wang H; Li H; Peng Q; Wei D; Chen C; Zheng J
    Molecules; 2017 Mar; 22(3):. PubMed ID: 28300751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological Activity, Apoptotic Induction and Cell Cycle Arrest of New Hydrazonoyl Halides Derivatives.
    Mohamed MF; Hassaneen HM; Elzayat EM; El-Hallouty SM; El-Manawaty M; Saleh FM; Mohamed Y; El-Zohiry D; Fahmy G; Abdelaal N; Hassanin N; Hossam N
    Anticancer Agents Med Chem; 2019; 19(9):1141-1149. PubMed ID: 30843494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and biological evaluation of novel pyrazoline-containing derivatives as potential tubulin assembling inhibitors.
    Qin YJ; Li YJ; Jiang AQ; Yang MR; Zhu QZ; Dong H; Zhu HL
    Eur J Med Chem; 2015 Apr; 94():447-57. PubMed ID: 25828827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor potential of 1-thiocarbamoyl-3,5-diaryl-4,5-dihydro-1H-pyrazoles in human bladder cancer cells.
    Tessmann JW; Buss J; Begnini KR; Berneira LM; Paula FR; de Pereira CMP; Collares T; Seixas FK
    Biomed Pharmacother; 2017 Oct; 94():37-46. PubMed ID: 28750358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of 1,3,5-triphenyl-4,5-dihydro-1H-pyrazole derivatives on cell-cycle and apoptosis in human acute leukemia cell lines.
    Santos Bubniak LD; Gaspar PC; de Moraes ACR; Bigolin A; de Souza RK; Buzzi FC; Corrêa R; Filho VC; Bretanha LC; Micke GA; Nunes RJ; Santos-Silva MC
    Can J Physiol Pharmacol; 2017 May; 95(5):548-563. PubMed ID: 28177693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel series of thiazolyl-pyrazoline derivatives: synthesis and evaluation of antifungal activity, cytotoxicity and genotoxicity.
    Altıntop MD; Özdemir A; Turan-Zitouni G; Ilgın S; Atlı Ö; Demirel R; Kaplancıklı ZA
    Eur J Med Chem; 2015 Mar; 92():342-52. PubMed ID: 25576739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Facile and efficient access to Androsten-17-(1',3',4')-pyrazoles and Androst-17β-(1',3',4')-pyrazoles via Vilsmeier reagents, and their antiproliferative activity evaluation in vitro.
    Li J; Huo H; Guo R; Liu B; Li L; Dan W; Xiao X; Zhang J; Shi B
    Eur J Med Chem; 2017 Apr; 130():1-14. PubMed ID: 28237792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and biological evaluation of 1,3-diphenyl-1H-pyrazole derivatives containing benzimidazole skeleton as potential anticancer and apoptosis inducing agents.
    Reddy TS; Kulhari H; Reddy VG; Bansal V; Kamal A; Shukla R
    Eur J Med Chem; 2015 Aug; 101():790-805. PubMed ID: 26231080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and biological evaluation of 1, 4-dihydro indeno[1,2-c] pyrazole linked oxindole analogues as potential anticancer agents targeting tubulin and inducing p53 dependent apoptosis.
    Khan I; Garikapati KR; Shaik AB; Makani VKK; Rahim A; Shareef MA; Reddy VG; Pal-Bhadra M; Kamal A; Kumar CG
    Eur J Med Chem; 2018 Jan; 144():104-115. PubMed ID: 29268127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel series of pyrazole-platinum(II) complexes as potential anti-cancer agents that induce cell cycle arrest and apoptosis in breast cancer cells.
    Czarnomysy R; Surażyński A; Muszynska A; Gornowicz A; Bielawska A; Bielawski K
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1006-1023. PubMed ID: 29862867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and stereoselective synthesis of novel isosteviol-fused pyrazolines and pyrazoles as potential anticancer agents.
    Zhu SL; Wu Y; Liu CJ; Wei CY; Tao JC; Liu HM
    Eur J Med Chem; 2013 Jul; 65():70-82. PubMed ID: 23693151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and biological evaluation of some new 2-Pyrazoline derivatives as potential anticancer agents.
    Tok F; İrem Abas B; Çevik Ö; Koçyiğit-Kaymakçıoğlu B
    Bioorg Chem; 2020 Sep; 102():104063. PubMed ID: 32663669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, EGFR Inhibition and Anti-cancer Activity of New 3,6-dimethyl-1-phenyl-4-(substituted-methoxy)pyrazolo[3,4-d] pyrimidine Derivatives.
    Bakr RB; Mehany ABM; Abdellatif KRA
    Anticancer Agents Med Chem; 2017; 17(10):1389-1400. PubMed ID: 28270084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis and biological evaluation of a new series of thiazolyl-pyrazolines as dual EGFR and HER2 inhibitors.
    Sever B; Altıntop MD; Radwan MO; Özdemir A; Otsuka M; Fujita M; Ciftci HI
    Eur J Med Chem; 2019 Nov; 182():111648. PubMed ID: 31493743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyrazoline analogs as potential anticancer agents and their apoptosis, molecular docking, MD simulation, DNA binding and antioxidant studies.
    Rana M; Arif R; Khan FI; Maurya V; Singh R; Faizan MI; Yasmeen S; Dar SH; Alam R; Sahu A; Ahmad T; Rahisuddin
    Bioorg Chem; 2021 Mar; 108():104665. PubMed ID: 33571809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of novel 4(1H)-quinolone derivatives as potential antiproliferative and apoptosis inducing agents.
    Zhou P; Huang L; Zhou J; Jiang B; Zhao Y; Deng X; Zhao Q; Li F
    Bioorg Med Chem Lett; 2017 Sep; 27(17):4185-4189. PubMed ID: 28757067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, in vitro Antiproliferative and Antiinflammatory Activities, and Kinase Inhibitory effects of New 1,3,4-triarylpyrazole Derivatives.
    El-Gamal MI; Abdel-Maksoud MS; Gamal El-Din MM; Shin JS; Lee KT; Yoo KH; Oh CH
    Anticancer Agents Med Chem; 2017; 17(1):75-84. PubMed ID: 27334850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel pyrazolo[3,4-d]pyrimidines: design, synthesis, anticancer activity, dual EGFR/ErbB2 receptor tyrosine kinases inhibitory activity, effects on cell cycle profile and caspase-3-mediated apoptosis.
    Maher M; Kassab AE; Zaher AF; Mahmoud Z
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):532-546. PubMed ID: 30688116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and preliminary mechanistic evaluation of 5-(p-tolyl)-1-(quinolin-2-yl)pyrazole-3-carboxylic acid amides with potent antiproliferative activity on human cancer cell lines.
    Cankara Pirol Ş; Çalışkan B; Durmaz I; Atalay R; Banoglu E
    Eur J Med Chem; 2014 Nov; 87():140-9. PubMed ID: 25247770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.